Xudan Wang

Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

PPARγ suppresses the tumorigenesis of retroperitoneal liposarcoma via inactivation of the PI3K/AKT signaling pathway.

PPARγ suppresses the tumorigenesis of retroperitoneal liposarcoma via inactivation of the PI3K/AKT signaling pathway.

Journal: Journal of translational medicine
Published: March 21, 2026

Decoding the resistin-CAP1 pathway in intermediate monocytes mediating liver allograft rejection.

Decoding the resistin-CAP1 pathway in intermediate monocytes mediating liver allograft rejection.

Journal: Journal of hepatology
Published: July 17, 2024

EREG silencing inhibits tumorigenesis via inactivating ERK/p38 MAPK pathway in pancreatic ductal adenocarcinoma.

EREG silencing inhibits tumorigenesis via inactivating ERK/p38 MAPK pathway in pancreatic ductal adenocarcinoma.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: February 12, 2024

Research progress on anatomy reconstruction of rat orthotopic liver transplantation.

Research progress on anatomy reconstruction of rat orthotopic liver transplantation.

Journal: Transplantation reviews (Orlando, Fla.)
Published: January 08, 2024

Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD.

Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD.

Journal: Journal of hepatology
Published: September 25, 2023

Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery.

Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery.

Journal: Frontiers in oncology
Published: February 27, 2023

ASRGL1 downregulation suppresses hepatocellular carcinoma tumorigenesis in a CDK1-dependent manner.

ASRGL1 downregulation suppresses hepatocellular carcinoma tumorigenesis in a CDK1-dependent manner.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: July 06, 2022

Construction and experimental verification of user-friendly molecular subtypes mediated by immune-associated genes in hepatocellular carcinoma.

Construction and experimental verification of user-friendly molecular subtypes mediated by immune-associated genes in hepatocellular carcinoma.

Journal: Frontiers in oncology
Published: April 20, 2022

Prognosis-related genes participate in immunotherapy of renal clear cell carcinoma possibly by targeting dendritic cells.

Prognosis-related genes participate in immunotherapy of renal clear cell carcinoma possibly by targeting dendritic cells.

Journal: Frontiers in cell and developmental biology
Published: March 28, 2022

A Bionic Self-Assembly Hydrogel Constructed by Peptides With Favorable Biosecurity, Rapid Hemostasis and Antibacterial Property for Wound Healing.

A Bionic Self-Assembly Hydrogel Constructed by Peptides With Favorable Biosecurity, Rapid Hemostasis and Antibacterial Property for Wound Healing.

Journal: Frontiers in bioengineering and biotechnology
Published: March 22, 2022

Potentiality of α-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma.

Potentiality of α-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma.

Journal: Bioengineered
Published: October 26, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026